CEO Today USA Awards

www.ceotodaymagazine.com 26 CEO Today USAAwards 2017 CALIFORNIA Our story began over a decade ago, when Amyris was founded with a vision of making a positive impact on the world through science. Amyris first used its proprietary process to convert plant- sugars into an alternative, lower cost, stable supply of artemisinin, an effective anti-malarial. Thanks to our breakthrough technology, we have stabilized the cost and made accessible the world’s leading treatment for malaria, saving up to one- million children a year. We engineer organisms (yeast) through this process and our powerful technology platform so that they take renewably- sourced carbon from plants to make exactly the molecule our customers need to make better products that enable a healthier Earth. Amyris is the only company that has scaled and manufactures new products powered by unique ingredients made accessible by highly engineered organisms that are cost advantaged and are delivering high-performance products for our customers, their consumers and our planet. Today, Amyris is one of the fastest-growing industrial biotechnology companies and is delivering products that are disrupting markets for our customers in several of the world’s largest and rapidly-growing industries. www.amyris.com FIRM PROFILE ABOUT JOHN MELO John Melo has 30 years of combined experience as an entrepreneur and thought leader in developing and growing technology companies and as a senior executive in the Oil & Gas industry. As President and Chief Executive Officer, Mr. Melo has led Amyris through successful technology development, industrial start up, product development and commercialization and a series of funding rounds, including the initial public offering. Before joining Amyris in 2007, Mr. Melo served in various senior executive positions at BP Plc (formerly British Petroleum) most recently as President of U.S. fuels operations where he successfully led a business transformation and significantly improved the financial performance. During his tenure at BP, Mr. Melo also served as Chief Information Officer of the refining and marketing segment; Senior Advisor for e-business strategy to Lord Browne, BP group chief executive; and Director of global brand development. In this last role, he helped develop the “Helios” re-branding effort. Before joining BP, Mr. Melo was with Ernst & Young. Mr. Melo currently serves on the board of directors of Renmatix Inc., serves on the board of directors of BayBio, serves on the Bio Industrial and Environmental section governing board, is a member of the Council for the Portuguese Diaspora and is a member of Young Presidents’ Organization (YPO). He was formerly an appointed member to the U.S. section of the U.S.-Brazil CEO Forum. When not working on the mission of making sustainable chemistry mainstream or championing the eradication of malaria, John enjoys skiing, reading and time with his family on the island of Pico in the Azores, his childhood home. JOHN MELO President & Chief Executive Officer at Amyris